How big is the Hemophilia Market?

The Hemophilia Market size is expected to reach USD 13.66 billion in 2024 and grow at a CAGR of 5.5% to reach USD 17.86 billion by 2028. Read More

What is the current Hemophilia Market size?

In 2024, the Hemophilia Market size is expected to reach USD 13.66 billion. Read More

Who are the key players in Hemophilia Market?

Pfizer, Inc., Bayer AG, Novo Nordisk A/S, CSL Limited (CSL Behring) and BioMarin are the major companies operating in the Hemophilia Market. Read More

Which is the fastest growing region in Hemophilia Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Hemophilia Market?

In 2024, the North America accounts for the largest market share in Hemophilia Market. Read More

What years does this Hemophilia Market cover, and what was the market size in 2023?

In 2023, the Hemophilia Market size was estimated at USD 12.91 billion. The report covers the Hemophilia Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Hemophilia Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key factors driving the growth of the home-based Hemophilia Treatment Market?

The key factors driving the growth of the home-based Hemophilia Treatment Market are a) Advancements in self-administration technologies b) Patient preference for home care c) Impact on treatment adherence Read More

Hemophilia Market Share

Statistics for the 2023 & 2024 Hemophilia market share, created by Mordor Intelligence™ Industry Reports. Hemophilia share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Hemophilia Industry

The hemophilia market is semi consolidated in nature and consists of a few major players. The key players are also involved in various strategic alliances such as acquisitions, collaborations, and launching advanced products and research studies to secure their position in the global market. Some of the key market players in this market include Bayer AG, BioMarin, CSL Limited (CSL Behring), Novo Nordisk, Pfizer Inc., Sanofi (Genzyme Corporation), and Takeda Pharmaceutical Company Limited (Shire PLC).